Statistics

Total Visits

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis23

Select a period of time:

Number of views in the range

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis18

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20253
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States3
 

Top cities views

Views